CYP2A6 and breast carcinoma: Martinez et al. [15] compared the expression of CYP450 superfamily members and other transcription factors related to drug metabolism by analyzing control samples of breast cancer and normal breast tissues, and the results showed that the expression levels of CYP1B1, CYP2A6, GST-A4, etc., are increased in breast cancer.